从良性到恶性：垂体神经内分泌肿瘤 (PitNETs) 的出现。
From Benign to Malignant: The Arrival of Pituitary Neuroendocrine Tumors (PitNETs).
机构信息
Address of Correspondent: Munich Re, 1000 Rue de la Gauchetière Ouest, 20e étage, Montréal Québec, H3B 4W5; 514-392-5069;
出版信息
J Insur Med. 2023 Jul 1;50(2):154-156. doi: 10.17849/insm-50-2-154-156.1.
Pituitary adenomas were recently reclassified as "neuroendocrine tumors," and are now considered to be cancers. The evolution and justification for this change are described. Critical illness policies, which currently provide coverage of pituitary adenomas under the "Benign Brain Tumor" provision must now be modified to reflect this new taxonomy. This change also prompts questions about the use of the words 'benign' and 'tumor' in critical illness policies.
垂体腺瘤最近被重新归类为“神经内分泌肿瘤”，现在被认为是癌症。描述了这一变化的演变和依据。目前在“良性脑瘤”条款下为垂体腺瘤提供保险的重大疾病政策现在必须进行修改，以反映这一新的分类。这一变化也引发了关于重大疾病政策中使用“良性”和“肿瘤”这两个词的问题。
Zotero 插件